Access Pharmaceuticals Announces Positive Top-Line Data From MuGarda Phase IV Clinical Trial In Oral Mucositis Patients Presented At MASCC/ISOO 2013 Symposium , presented top-line results today from a phase IV clinical trial evaluating MuGard Mucoadhesive Oral Wound Rinse at the MASCC/ISOO International Symposium on Supportive Care in Cancer in .
http://www.biospace.com/news_story.aspx?StoryID=301357&full=1
http://www.biospace.com/news_story.aspx?StoryID=301357&full=1
No comments:
Post a Comment